Abstract：Objective: To investigate the effect of serum soluble cluster of differentiation 14 subtype (sCD14-ST) combined with urinary neutrophil gelatinase-associated lipocalin (NGAL) on the early diagnosis of acute kidney injury (AKI) in patients with sepsis. Methods: 132 patients with sepsis from October 2015 to December 2018 were selected and divided into AKI group (n=41) and non-AKI group (n=91) according to presence or absence of AKI. Then the serum creatinine (Scr), sCD14-ST, and urinary NGAL levels at 0, 4, 8, 12, 24 hours after sepsis were measured and analyzed. Results: ①The hospitalization time and 30-day mortality rate in the AKI group were significantly higher than those in the non-AKI group (P<0.05). ②There was no significant difference in serum Scr levels at 0, 4 and 8 hours in AKI group (P>0.05). The serum Scr level at 12 hours was significantly higher than those at 0, 4, 8 hours and non-AKI group, and the serum Scr levels at 24 hours was significantly higher than those at 0, 4, 8, 12 hours and non-AKI group(P<0.05). There was no significant difference in serum sCD14-ST and urinary NGAL levels at 0, 4 hours in AKI group (P>0.05). The levels of sCD14-ST in blood at 8 hours, 12 hours and 24 hours were significantly higher than those at 0h, 4 hours and non-AKI groups, and the levels of sCD14-ST in blood at 24 hours were significantly higher than those at 8 hours(P<0.05), and the levels of urine NGAL at 12 hours and 24 hours were significantly higher than those in 0, 4 hours and non-AKI groups, and the levels of NGAL in urine at 12 hours and 24 hors were significantly higher than those in 8 hours, and the urine at 24 hours was significantly higher than those in 12 hours (P<0.05). The blood Scr, sCD14-ST and urinary NGAL levels within non-AKI group at the post 0h had no difference with those of any other time points (P>0.05). ③ ROC curve analysis showed that the serum sCD14-ST threshold value was 927.50pg/mL, the sensitivity and specificity were 90.12% and 83.63%, respectively; the urine NGAL threshold value was 85ng/mL, and the sensitivity and specificity were 89.36% and 84.34%, respectively. The sensitivity and specificity of serum sCD14-ST combined with urinary NGAL for early diagnosis of sepsis in patients with sepsis were 91.45% and 86.23%, respectively. Conclusion: Serum sCD14-ST combined with urinary NGAL has a high predictive value for early diagnosis of sepsis in patients with sepsis, which is worthy of clinical application.
贺晓雯, 徐玉祥, 张九芝, 马刚. 血sCD14-ST联合尿NGAL对早期诊断脓毒血症并发AKI患者的临床价值[J]. 河北医学, 2019, 25(11): 1765-1769.
HE Xiaowen, XU Yuxiang, ZHANG Jiuzhi, et al. Clinical Value of Blood sCD14-ST Combined with Urinary NGAL on Early Diagnosis of Acute Kidney Injury in Patients with Sepsis. HeBei Med, 2019, 25(11): 1765-1769.
[1] 崔岩,张新超,银彩霞,等.Presepsin(sCD14-ST)检测对脓毒症急诊患者的诊断意义和预后评估价值[J].中华医院感染学杂志,2017,27(1):75~78. [2] 李平华,宋倩,黄连铭.血清肌酐、胱抑素C、NGAL检测对妊娠相关急性肾损伤诊断及预后评估的价值[J].中国计划生育学杂志,2017,25(5):308~313. [3] Enguix-Armada A, Escobar-Conesa R, Garcia-De La Torre A, et al. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin[J]. Clin Chem Lab Med, 2016, 54(1):163~168. [4] Kellum JA. Diagnostic criteria for acute kidney injury: present and future[J]. Crit Care Clin, 2015, 31(4):621~632. [5] 裴华,胡浩荣,谭华侨,等.PCT、LAC/ScvO2对脓毒血症患者病情与预后的评估价值[J].现代医学,2016,44(10):1419~1422. [6] 刘亚红,高倩,郑慧霄.尿NGAL联合尿沉渣评分在预测糖尿病肾病并发急性肾损伤预后中的临床价值[J].中国卫生检验杂志,2018,28(13):1562~1564. [7] 杜航,韦宝花,董晨明.脓毒症急性肾损伤病理生理机制及早期识别生物标记物研究进展[J].西北国防医学杂志,2018,39(1):67~70. [8] 全锦花,杨鲁,张新超.血清presepsin(sCD14-ST)联合NEWS评分评估脓毒症患者预后的价值[J].中华急诊医学杂志,2017,26(8):1347~1349. [9] Klouche K, Cristol JP, Devin J, et al. Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients[J]. Ann Intensive Care, 2016, 6(1):59. [10] 郝林涛,韩凌,邹作君.尿NGAL和血、尿胱抑素C对早期糖尿病肾脏疾病诊断价值的研究[J].中国中西医结合肾病杂志,2016,17(3):240~242. [11] 胡明磊,金献冠,李钰,等.脓毒症AKI生物学标志物在CRRT中的临床价值[J].医学研究杂志,2017,46(9):100~103.
2019, Vol. 25 
冀公网安备13080202000677号